ArticleAllergologie select2021

Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis.

Askin Gülsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.